Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NASDAQ:MDGN)

5.00
Delayed Data
As of Dec 02
 -0.06 / -1.19%
Today’s Change
3.09
Today|||52-Week Range
7.18
-16.94%
Year-to-Date
No recent news for Medgenics Inc.

Today’s Trading

Previous close5.06
Today’s open5.08
Day’s range4.96 - 5.14
Volume149,464
Average volume (3 months)135,895
Market cap$185.5M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-45.00%
Earnings growth (this year)+12.76%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
MDGLMadrigal Pharmaceuti...-0.19-1.18%
ARGSArgos Therapeutics I...+0.25+5.62%
CNCEConcert Pharmaceutic...+0.07+0.81%
AGRXAgile Therapeutics I...+0.01+0.15%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$38.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
Chief Financial Officer
Brian D. Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts


Search for Jobs